SODIUM-GLUCOSE COTRANSPORTER-2 INHIBITORS

Clinical trials for SODIUM-GLUCOSE COTRANSPORTER-2 INHIBITORS explained in plain language.

Never miss a new study

Get alerted when new SODIUM-GLUCOSE COTRANSPORTER-2 INHIBITORS trials appear

Sign up with your email to follow new studies for SODIUM-GLUCOSE COTRANSPORTER-2 INHIBITORS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet recruiting 1

New hope for fontan hearts: common drug gets special trial

Disease control Not yet recruiting

This study is testing if a drug called dapagliflozin can help people who have had a Fontan heart surgery. It aims to see if the drug improves their ability to exercise and their heart function over three months. The trial will involve about 30 adolescents and adults in Hong Kong …

Matched conditions: SODIUM-GLUCOSE COTRANSPORTER-2 INHIBITORS

Phase: PHASE4 • Sponsor: The University of Hong Kong • Aim: Disease control

Last updated Mar 30, 2026 14:33 UTC

SODIUM-GLUCOSE COTRANSPORTER-2 INHIBITORS

Get alerted when new SODIUM-GLUCOSE COTRANSPORTER-2 INHIBITORS trials appear

New hope for fontan hearts: common drug gets special trial